Global Next Generation Sequencing Computing (NGS) Market by Service, Application, End User, and Geography Forecast to 2024 –

DUBLIN – (COMMERCIAL THREAD) – The report “Global Next Generation Sequencing Computing Market – Segmented by Service, Application, End User and Geography – Growth, Trends and Forecast (2019 – 2024)” has been added to

The global next-generation sequencing computing market is expected to register a CAGR of around 22% during the period 2018-2023 (the forecast period). North America dominates the market, due to the growing demand for NGS IT products and services in the region.

Growing demand for NGS service and increased investments from key players

Next Generation Sequencing Computing Services (NGS) have grown in popularity in recent years, due to the growing demand for NGS services in the screening and early detection of chronic diseases, globally.

The adoption of IT tools in NGS has resulted in reduced costs and rapid turnaround times, which has propelled the adoption of NGS services over traditional methods of microarray, capillary electrophoresis (CE) and Sanger. This factor is likely to drive demand for NGS services in the detection of chronic diseases, such as cancer, diabetes, chronic kidney disease and cardiovascular disease, among others.

Increased investment by private players in the development of new low cost NGS systems and the development of new analysis and interpretation software tools have further increased the growth of the NGS IT services market.

In addition, the increase in clinical applications of NGS, technological advancements in NGS computing tools, growing preference for personalized drugs are the factors that are fueling the next generation sequencing computing market.

Lack of qualified technicians

Insufficient qualified professionals for the analysis and interpretation of NGS data and lack of knowledge of new computing tools among healthcare professionals are likely to limit the growth of the next generation sequencing computing market. Moreover, the high cost of maintenance and security of IT tools is likely to restrain the growth of the NGS IT market.

Lack of reimbursement, ethical challenges, and the high cost of some advanced next-generation sequencing systems and tools are likely to hold back the growth of the market.

North America dominates the market

The Next Generation Sequencing Computing market has been segmented on the basis of type of service, application, end user, and geography. By geography, this market has been segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America.

Due to the presence of well established healthcare facilities and the growing demand for high throughput computing tools, due to the launch of high throughput sequencing equipment and genome sequencing projects at scale of the population in the region, North America dominates the next generation sequencing computing market.

The market for next-generation sequencing computing in Asia-Pacific is also expected to grow owing to factors such as improved accessibility to healthcare facilities in the region, increased sequencing adoption rate from new generation in drug discovery, increased public and private sector investment in genome sequencing projects and the entry of global players into this lucrative market.

Developments in the market

  • January 2018: Genomics England adopted Edico’s Dragen Bio-IT platform to process alignment and variant calling of whole genome sequencing data.

  • October 2017: Bluebee and Pacific Biosciences of California, Inc., the leader in long-read sequencing, announced the integration of the PacBio de novo assembly pipeline on the Bluebee genomic analysis platform. The integration creates a streamlined workflow and a fully automated end-to-end data analysis solution that enables the assembly of genomes of any size, including the human genome.

Key topics covered

1. Introduction

2. Research methodology

3. Executive summary

4. Key inferences

5. Market overview
5.1 Current market scenario
5.2 Porter’s five forces analysis

6. Analysis of drivers, constraints, opportunities and challenges (DROC)
6.1 Market drivers
6.1.1 Increasing clinical application of NGS
6.1.2 Technological advancement in NGS IT tools
6.1.3 Growing Preference for Personalized Medicines and Early Diagnosis of Disease
6.1.4 Growing demand for NGS services and increasing investments by major players
6.2 Market restrictions
6.2.1 Lack of qualified technicians for NGS IT services
6.2.2 High cost of NGS sequencing
6.3 Opportunities
6.4 Main challenges

7. Market segmentation
7.1 By service
7.1.1 Computer tools for NGS sequencing
7.1.2 Data analysis tools
7.1.3 Storage and calculation tools
7.1.4 Interpretation and reporting tools
7.1.5 Laboratory Information Management System (LIMS)
7.2 By application
7.2.1 Drug discovery
7.2.2 Genetic screening
7.2.3 Disease diagnosis
7.2.4 Precision drugs
7.2.5 Others
7.3 By the end user
7.3.1 Hospitals and clinics
7.3.2 Universities and research institutes
7.3.3 Pharmaceutical and biotechnology companies
7.4 By geography
7.4.1 North America
7.4.2 Europe
7.4.3 Asia-Pacific
7.4.4 Middle East and Africa
7.4.5 South America

8. Competitive landscape
8.1 Analysis of mergers and acquisitions
8.2 Agreements, collaborations and partnerships
8.3 New product launches

9. Key players
9.1 Amazon Web Services LLC
9.2 DNAnexus Inc.
9.3 F. Hoffmann-La Roche Ltée.
9.4 Genomatrix SA
9.5 Illumina Inc.
9.6 Omicia Inc.
9.7 Partek Incorporated
9.8 Qiagen SA
9.9 Sapio Sciences
9.10 Thermo Fischer Scientific Inc.
9.11 Others

10. Future of the market

For more information on this report visit

Veronica J. Snell

Leave a Reply

Your email address will not be published.